Phase IIb BID Results Recap In June 2025, MDR-001 BID dosing regimen achieved primary endpoints in the Phase IIb clinical trial, the results demonstrated that MDR-001 achieved a weight loss of up to ...

Boehringer Ingelheim today announced the launch of its new direct-to-consumer platform, “Boehringer Ingelheim Access.” The platform will offer a convenient way for patients in the U.S. to order and ...

Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® and the AYON Body ...

“We are pleased to continue to expand the protection surrounding our bioengineered tissue platform and related novel product candidates,” said Laura Niklason, M.D., Ph.D., Founder and Chief Executive ...

Elicio’s AMP platform, originally developed at the Massachusetts Institute of Technology, has broad potential in the cancer space to advance a number of development initiatives through internal ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...

Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed company building a long-term strategic treasury of Hyperliquid’s native token, HYPE, today ...

The B-90 blast freezer is engineered to rapidly freeze products, providing speed, efficiency, and reliability for industries where precision matters most. Customers include biopharmaceuticals and cold ...

Quotient Therapeutics, a company pioneering somatic genomics to inform breakthrough medicines, today announced that it has appointed Andrew (Andy) Bayliffe, PhD, as Chief Development Officer. Andy ...

Cosmos Health is at a turning point in its journey. We have aligned every business unit around a common goal: creating a global healthcare and life sciences platform that integrates pharmaceuticals, ...

Comes on the heels of Neura’s expansion into memory care, addressing a critical shortage in cognitive neurologists amid the growing ‘Silver Tsunami’ NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Neura ...